Ultimovacs ASA (ULTI.OL)
NOK 2.05
(0.0%)
NOK 2.05
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.71 Million NOK | -32.24% |
| 2022 | 5.48 Million NOK | 162.83% |
| 2021 | 2.08 Million NOK | -44.87% |
| 2020 | 3.78 Million NOK | 4.3% |
| 2019 | 3.62 Million NOK | 0.0% |
| 2018 | - NOK | 0.0% |
| 2017 | - NOK | 0.0% |
| 2016 | - NOK | 0.0% |
| 2015 | - NOK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.01 Million NOK | -15.8% |
| 2024 Q1 | 3.57 Million NOK | -3.69% |
| 2023 Q3 | 4.16 Million NOK | -9.66% |
| 2023 FY | 3.71 Million NOK | -32.24% |
| 2023 Q2 | 4.61 Million NOK | -8.67% |
| 2023 Q4 | 3.71 Million NOK | -10.94% |
| 2023 Q1 | 5.05 Million NOK | -7.79% |
| 2022 Q3 | 1.79 Million NOK | -1.75% |
| 2022 Q2 | 1.82 Million NOK | 5.18% |
| 2022 FY | 5.48 Million NOK | 162.83% |
| 2022 Q1 | 1.73 Million NOK | -16.64% |
| 2022 Q4 | 5.48 Million NOK | 205.12% |
| 2021 Q2 | 2.88 Million NOK | -13.58% |
| 2021 FY | 2.08 Million NOK | -44.87% |
| 2021 Q1 | 3.34 Million NOK | -11.61% |
| 2021 Q4 | 2.08 Million NOK | -16.03% |
| 2021 Q3 | 2.48 Million NOK | -14.05% |
| 2020 Q4 | 3.78 Million NOK | 0.69% |
| 2020 Q3 | 3.75 Million NOK | 7.28% |
| 2020 Q2 | 3.5 Million NOK | -10.37% |
| 2020 FY | 3.78 Million NOK | 4.3% |
| 2020 Q1 | 3.9 Million NOK | 7.72% |
| 2019 Q2 | 3.67 Million NOK | 0.0% |
| 2019 Q4 | 3.62 Million NOK | 5.59% |
| 2019 FY | 3.62 Million NOK | 0.0% |
| 2019 Q3 | 3.43 Million NOK | -6.46% |
| 2018 Q3 | - NOK | 0.0% |
| 2018 Q1 | - NOK | 0.0% |
| 2018 FY | - NOK | 0.0% |
| 2018 Q2 | - NOK | 0.0% |
| 2018 Q4 | - NOK | 0.0% |
| 2017 FY | - NOK | 0.0% |
| 2017 Q4 | - NOK | 0.0% |
| 2016 FY | - NOK | 0.0% |
| 2015 FY | - NOK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Arctic Bioscience AS | 2.04 Million NOK | -81.234% |
| Aqua Bio Technology ASA | 7.12 Million NOK | 47.875% |
| ArcticZymes Technologies ASA | 12.58 Million NOK | 70.506% |
| BerGenBio ASA | 418 Thousand NOK | -788.278% |
| Hofseth BioCare ASA | 136.78 Million NOK | 97.286% |
| PCI Biotech Holding ASA | 319 Thousand NOK | -1063.95% |
| Thor Medical ASA | - NOK | -Infinity% |